Search Criteria : India × NewDelhi ×
Mar 20 - 21, 2021 | CME : 6 | INR ₹7,500.00 | New Delhi, Delhi
4th World Cancer Congress - 2021 is organized by Arjyopa Healthcare. This Onsite medical conference will be held from Mar 20 - 21, 2021 at JNU Convention Center, New Delhi, Delhi, India. Who Should Attend: The 4th World Cancer Congress - 2020, Delhi offers a platform for the Oncologists and specialists both from Industry and Academia working in distinct sub-domains of Oncology varying from classical Oncology to the advanced technologies and image analysis in Oncology including Oncological Diagnosis and therapy. • Radiologists • Oncologists • Pharmacologists • Chemotherapists • Doctors • Oncology Institutes • Medical Colleges • Research faculty • Students • Diagnostic laboratory professionals • Business Entrepreneurs • Industry professionals • Directors/Managers/CEO • Presidents & Vice Presidents • Brand Manufacturers/ Marketers of Consumer Products • Marketing, Advertising & Promotion Agency Executives. Accreditation: This Congress has been recommended for a maximum of 6 CME Credit Points. Conference Description: We cordially invite all the attendees involved in bestowing their knowledge and research in the arena of Oncology and Cancer Research. We expect thousands of worldwide cancer and health experts to focalize to our capital city in November 2020, and take account of this major educational platform to further 'Strengthen. Inspire. Deliver’ global cancer control momentum. From the feedback collected, the previous Congresses resulted in fruitful collaborations and gratifying experiences for the representatives who left the events with concrete tools and solutions that assisted them to intensify their work practice and impact. As hosts, we already feel very excited to perform the same energetic and inspiring atmosphere throughout the Congress week in Delhi, adding local qualities and new perspectives such as the role of complementary treatment in cancer to the program. We are also hopeful that through Congress our community in Asia will be able to build awareness about the increasing cancer burden that affects our region and strengthen its ties to further tackle the disease. Studies estimate that 8.1 million people in Asia will die of cancer by 2020 - 75% of which will be inadequate to face the huge medical care costs within their first year of diagnosis. Thus, the critical need to mobilize our efforts, promote cancer advocacy more efficiently, and promote effective national policies and plans for prevention, early detection, care, and support We look forward to the honor of welcoming you to New Delhi, India. Why You Should Attend: The 4th World Cancer Congress - 2020 is one of the world-leading international cancer conferences. The 4th World Cancer Congress - 2020 organized by Arjyopa Healthcare combines researchers with various expertise in cancer research along with oncologists to consider the most intensively pursued topics of investigation. The aim and goal of the medical conference are to bridge basic and clinical aspects of the genesis, progression, prognosis, prevention, and treatment of cancer. The conference is converged upon disease management, prevention, procedures for early diagnosis, specific classes of therapeutic agents, results of a clinical trial, an emerging interventional method, supportive care, and rehabilitation/reconstruction. The Summit has been received in one of Mumbai, will set a perfect backdrop for The 4th World Cancer Congress-2020. The conference will present an ideal platform for knowledge transfer, B2B networking, and collaborations along with a delightful experience of a scientific meeting combined with social evenings. Key Tracks: • Track 1: Bladder Cancer • Track 2: Bone Cancer • Track 3: Brain Cancer • Track 4: Breast Cancer • Track 5: Cancer Genetics & Genomics • Track 6: Cancer Immunotherapy & Vaccines • Track 7: Cancer Metabolism • Track 8: Cell Signalling & Regulation • Track 9: Cell-Based Therapy • Track 10: Chemical Biology • Track 11: Chronic Myeloid Leukemia • Track 12: Chronic Lymphocytic Leukemia • Track 13: Developmental Biology • Track 14: Endocrine Cancer • Track 15: Epidemiology • Track 16: Epigenetics • Track 17: Exercises Oncology • Track 18: Imaging • Track 19: Immunology • Track 20: Lung Cancer • Track 21: Lymphoma • Track 22: Palliative Care • Track 23: Genome Integrity • Track 24: Gynecologic Cancer • Track 25: Microbiome & Inflammation • Track 26: Molecular Pathology & Diagnostics • Track 27: Multiple Myeloma • Track 28: Nanotechnology • Track 29: Neuroscience & Neuro-Oncology • Track 30: Renal Cell Carcinoma • Track 31: Sarcoma • Track 32: Skin Cancer • Track 33: Side Effect Management • Track 34: Solid Tumor Oncogenesis • Track 35: Stem Cells • Track 36: Structural Biology • Track 37: Systems Biology • Track 38: Targeted Therapy • Track 39: Tumor Micro Environment • Track 40: Urologic Cancers • Track 41: Pancreatic Cancer • Track 42: Pediatric Cancer • Track 43: Prostate Cancer • Track 44: Gastrointestinal Cancer • Track 45: Head & Neck Cancer • Track 46: Hematologic Malignancies • Track 47: HPV & Cervical Cancer • Track 48: Metastasis & Drug Resistance
Society of Pharmaceutical Education & Research (SPER) Gastroenterology Conference & Healthcare Awards 2020
Dec 20, 2020 | INR ₹5,000.00 | New Delhi, Delhi
Society of Pharmaceutical Education & Research (SPER) Gastroenterology Conference & Healthcare Awards 2020 is organized by Society of Pharmaceutical Education & Research (SPER) and will be held on Dec 20, 2020 at Crowne Plaza New Delhi Okhla, New Delhi, Delhi, India. Theme: Current Research and Developments in Gastroenterology, Hepatology and Endoscopy Additional details will be posted as soon as information is available.
Expodent International India 2020 is organized by Association of Dental Industry and Trade of India (ADITI) and will be held from Dec 25 - 27, 2020 at New Delhi, Delhi, India. Additional details will be posted as soon as information is available.